Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

This study has been withdrawn prior to enrollment.
(Insufficient enrollment)
Sponsor:
Information provided by (Responsible Party):
Mark Nehler, MD, Colorado Prevention Center
ClinicalTrials.gov Identifier:
NCT00657514
First received: April 8, 2008
Last updated: August 13, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)